Daloyon, Helen S.

HRN: 22-28-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2022
CEFTRIAXONE 1G (VIAL)
12/04/2022
12/10/2022
IV
1g
Q12
T/C Complicated UTI
Waiting Final Action 
12/05/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/05/2022
12/12/2022
IV
500mg
Q8
T/C Hepatic Enceph
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: